These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15601445)

  • 1. Pharmacokinetics and pharmacokinetic/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors.
    Toutain PL; Lefèbvre HP
    J Vet Pharmacol Ther; 2004 Dec; 27(6):515-25. PubMed ID: 15601445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs.
    Toutain PL; Lefebvre HP; Laroute V
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1094-103. PubMed ID: 10688628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic/pharmacodynamic modeling approach.
    Toutain PL; Lefebvre HP; King JN
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1087-93. PubMed ID: 10688627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.
    Brockmeier D
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):631-8. PubMed ID: 8963479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
    McKellar QA; Sanchez Bruni SF; Jones DG
    J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model.
    Francis RJ; Brown AN; Kler L; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):32-8. PubMed ID: 2434791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors.
    LeBlanc JM; Dasta JF; Pruchnicki MC; Schentag JJ
    J Clin Pharmacol; 2006 Sep; 46(9):968-80. PubMed ID: 16920891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma terminal half-life.
    Toutain PL; Bousquet-Mélou A
    J Vet Pharmacol Ther; 2004 Dec; 27(6):427-39. PubMed ID: 15601438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
    Desmoulins PO; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats.
    King JN; Maurer M; Toutain PL
    J Vet Pharmacol Ther; 2003 Jun; 26(3):213-24. PubMed ID: 12755906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses.
    Serrano-Rodríguez JM; Gómez-Díez M; Esgueva M; Castejón-Riber C; Mena-Bravo A; Priego-Capote F; Ayala N; Caballero JMS; Muñoz A
    Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect assessment of tissue angiotensin II converting enzyme inhibition in vivo in man.
    Lees KR; Kelman AW; Whiting B; Reid JL
    J Hypertens Suppl; 1988 Dec; 6(3):S55-6. PubMed ID: 3225689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.
    Tagawa K; Mizobe M; Noda K
    Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterinary advances in PK/PD modelling.
    Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):395. PubMed ID: 15601435
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical interpretation of pharmacokinetic and pharmacodynamic data in zoologic companion animal species.
    Kukanich B
    Vet Clin North Am Exot Anim Pract; 2011 Jan; 14(1):1-20. PubMed ID: 21074699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.